Ursodeoxycholic Acid at 18–22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis

Table 8

Adverse reactions through the course of the trial.

	13–15 mg/kg/d	18–22 mg/kg/d
	(n = 36)	(n = 37)
Diarrhea	0	2
Nausea and vomiting	1	1
Rash	1	1
High blood pressure	1	0